# CARDINAL HEALTH INC (CAH) — capital_raise [announced]
Source: SEC API (secapi.ai) · situation sit_19fb92047e39d7d59f1d · retrieved 2026-08-14T01:38:48.869Z

## Overview
Cardinal Health, Inc. is a wholesale distributor of drugs, proprietaries and druggists' sundries.

Cardinal Health, Inc. entered into an unsecured Credit Agreement on August 7, 2026 with Wells Fargo Bank, National Association as Administrative Agent, and multiple lenders including Wells Fargo Securities, BofA Securities, Goldman Sachs Bank USA, and JPMorgan Chase Bank as Joint Lead Arrangers and Joint Bookrunners. The new facility provides $4.0 billion of revolving credit available through August 7, 2031, with the Company permitted to extend the termination date by up to two years subject to certain conditions. The Credit Agreement replaced the Company's existing Five-Year Credit Agreement (dated February 27, 2023, providing $2.0 billion), its 364-Day Credit Agreement (dated October 7, 2025, providing $1.0 billion), and its receivables sale facility program ($1.0 billion committed receivables sale program). No penalties were incurred by the Company as a result of the terminations.

## Terms
- Counterparty: Wells Fargo Bank, National Association (Administrative Agent); Wells Fargo Securities, LLC, BofA Securities, Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A. (Joint Lead Arrangers); Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., Barclays Bank plc, Deutsche Bank AG New York Branch, HSBC Bank USA, National Association, PNC Bank, National Association, The Bank of Nova Scotia (Documentation Agents) · Deal value: $4.00B

## Key dates
- Announced 2026-08-11 · Expiry 2031-08-07

## Timeline
- 2026-08-11 · 8-K (0000721371-26-000036): 8-K - CARDINAL HEALTH INC — *Cardinal Health, Inc. is a wholesale distributor of drugs, proprietaries and druggists' sundries.* Cardinal Health, Inc. entered into an unsecured Credit Agreement on August 7, 2026 with Wells Fargo Bank, National Association as Administrative Agent, and multiple lenders including Wells Fargo Securities, BofA Securities, Goldman Sachs Bank USA, and JPMorgan Chase Bank as Joint Lead Arrangers and Joint Bookrunners. The new facility provides $4.0 billion of revolving credit available through August 7, 2031, with the Company permitted to extend the termination date by up to two years subject to certain conditions. The Credit Agreement replaced the Company's existing Five-Year Credit Agreement (dated February 27, 2023, providing $2.0 billion), its 364-Day Credit Agreement (dated October 7, 2025, providing $1.0 billion), and its receivables sale facility program ($1.0 billion committed receivables sale program). No penalties were incurred by the Company as a result of the terminations.
  https://www.sec.gov/Archives/edgar/data/721371/0000721371-26-000036.txt

## Citations
- 0000721371-26-000036 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000072137126000036